Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt European Medicines Agency reviews treatment recommendations for Fabrazyme 22 oktober 2010Press releaseHumanMedicines European Medicines Agency recommends use of fibrates as second-line treatment 22 oktober 2010Press releaseMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 18-21 October 2010 22 oktober 2010Press releaseHuman European Medicines Agency concludes that benefit-risk balance of Invirase remains positive 21 oktober 2010Press releaseHumanMedicines Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 12-13 October 2010 15 oktober 2010Press releaseVeterinary European Medicines Agency strengthens rules on conflicts of interests of its scientific experts 14 oktober 2010Press releaseCorporateMedicines New fees for marketing authorisation applications in force 13 oktober 2010News European Medicines Agency publishes second work package of benefit-risk methodology project 13 oktober 2010NewsMedicines European Medicines Agency Management Board adopt new policies on handling of conflicts of interests and on access to documents 8 oktober 2010Press releaseCorporate European Medicines Agency receives 1,000th application for a Paediatric Investigation Plan or Waiver 8 oktober 2010NewsHumanMedicinesPaediatrics 1 … 282 283 284 285 286 Page 286 of 380 287 288 289 290 … 380
European Medicines Agency reviews treatment recommendations for Fabrazyme 22 oktober 2010Press releaseHumanMedicines
European Medicines Agency recommends use of fibrates as second-line treatment 22 oktober 2010Press releaseMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 18-21 October 2010 22 oktober 2010Press releaseHuman
European Medicines Agency concludes that benefit-risk balance of Invirase remains positive 21 oktober 2010Press releaseHumanMedicines
Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 12-13 October 2010 15 oktober 2010Press releaseVeterinary
European Medicines Agency strengthens rules on conflicts of interests of its scientific experts 14 oktober 2010Press releaseCorporateMedicines
European Medicines Agency publishes second work package of benefit-risk methodology project 13 oktober 2010NewsMedicines
European Medicines Agency Management Board adopt new policies on handling of conflicts of interests and on access to documents 8 oktober 2010Press releaseCorporate
European Medicines Agency receives 1,000th application for a Paediatric Investigation Plan or Waiver 8 oktober 2010NewsHumanMedicinesPaediatrics